Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications

Curtis A. Nutter, Neslihan Martinez

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Diabetes is a debilitating health care problem affecting 422 million people around the world. Diabetic patients suffer from multisystemic complications that can cause mortality and morbidity. Recent advancements in high-throughput next-generation RNA-sequencing and computational algorithms led to the discovery of aberrant posttranscriptional gene regulatory programs in diabetes. However, very little is known about how these regulatory programs are mis-regulated in diabetes. RNA-binding proteins (RBPs) are important regulators of posttranscriptional RNA networks, which are also dysregulated in diabetes. Human genetic studies provide new evidence that polymorphisms and mutations in RBPs are linked to diabetes. Therefore, we will discuss the emerging roles of RBPs in abnormal posttranscriptional gene expression in diabetes. Questions that will be addressed are: Which posttranscriptional mechanisms are disrupted in diabetes? Which RBPs are responsible for such changes under diabetic conditions? How are RBPs altered in diabetes? How does dysregulation of RBPs contribute to diabetes? Can we target RBPs using RNA-based methods to restore gene expression profiles in diabetic patients? Studying the evolving roles of RBPs in diabetes is critical not only for a comprehensive understanding of diabetes pathogenesis but also to design RNA-based therapeutic approaches for diabetic complications. WIREs RNA 2018, 9:e1459. doi: 10.1002/wrna.1459. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing Translation > Translation Regulation.

Original languageEnglish (US)
Article numbere1459
JournalWiley Interdisciplinary Reviews: RNA
Volume9
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

RNA-Binding Proteins
Bioelectric potentials
Diabetes Complications
Medical problems
RNA
Therapeutics
Gene expression
RNA Sequence Analysis
Medical Genetics
Alternative Splicing
Regulator Genes
Transcriptome
Polymorphism
Health care
Morbidity
Delivery of Health Care
Gene Expression
Mutation
Mortality
Genes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications. / Nutter, Curtis A.; Martinez, Neslihan.

In: Wiley Interdisciplinary Reviews: RNA, Vol. 9, No. 2, e1459, 01.03.2018.

Research output: Contribution to journalReview article

@article{3e603d11f8344b7b85656e744b0a3004,
title = "Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications",
abstract = "Diabetes is a debilitating health care problem affecting 422 million people around the world. Diabetic patients suffer from multisystemic complications that can cause mortality and morbidity. Recent advancements in high-throughput next-generation RNA-sequencing and computational algorithms led to the discovery of aberrant posttranscriptional gene regulatory programs in diabetes. However, very little is known about how these regulatory programs are mis-regulated in diabetes. RNA-binding proteins (RBPs) are important regulators of posttranscriptional RNA networks, which are also dysregulated in diabetes. Human genetic studies provide new evidence that polymorphisms and mutations in RBPs are linked to diabetes. Therefore, we will discuss the emerging roles of RBPs in abnormal posttranscriptional gene expression in diabetes. Questions that will be addressed are: Which posttranscriptional mechanisms are disrupted in diabetes? Which RBPs are responsible for such changes under diabetic conditions? How are RBPs altered in diabetes? How does dysregulation of RBPs contribute to diabetes? Can we target RBPs using RNA-based methods to restore gene expression profiles in diabetic patients? Studying the evolving roles of RBPs in diabetes is critical not only for a comprehensive understanding of diabetes pathogenesis but also to design RNA-based therapeutic approaches for diabetic complications. WIREs RNA 2018, 9:e1459. doi: 10.1002/wrna.1459. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing Translation > Translation Regulation.",
author = "Nutter, {Curtis A.} and Neslihan Martinez",
year = "2018",
month = "3",
day = "1",
doi = "10.1002/wrna.1459",
language = "English (US)",
volume = "9",
journal = "Wiley interdisciplinary reviews. RNA",
issn = "1757-7004",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications

AU - Nutter, Curtis A.

AU - Martinez, Neslihan

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Diabetes is a debilitating health care problem affecting 422 million people around the world. Diabetic patients suffer from multisystemic complications that can cause mortality and morbidity. Recent advancements in high-throughput next-generation RNA-sequencing and computational algorithms led to the discovery of aberrant posttranscriptional gene regulatory programs in diabetes. However, very little is known about how these regulatory programs are mis-regulated in diabetes. RNA-binding proteins (RBPs) are important regulators of posttranscriptional RNA networks, which are also dysregulated in diabetes. Human genetic studies provide new evidence that polymorphisms and mutations in RBPs are linked to diabetes. Therefore, we will discuss the emerging roles of RBPs in abnormal posttranscriptional gene expression in diabetes. Questions that will be addressed are: Which posttranscriptional mechanisms are disrupted in diabetes? Which RBPs are responsible for such changes under diabetic conditions? How are RBPs altered in diabetes? How does dysregulation of RBPs contribute to diabetes? Can we target RBPs using RNA-based methods to restore gene expression profiles in diabetic patients? Studying the evolving roles of RBPs in diabetes is critical not only for a comprehensive understanding of diabetes pathogenesis but also to design RNA-based therapeutic approaches for diabetic complications. WIREs RNA 2018, 9:e1459. doi: 10.1002/wrna.1459. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing Translation > Translation Regulation.

AB - Diabetes is a debilitating health care problem affecting 422 million people around the world. Diabetic patients suffer from multisystemic complications that can cause mortality and morbidity. Recent advancements in high-throughput next-generation RNA-sequencing and computational algorithms led to the discovery of aberrant posttranscriptional gene regulatory programs in diabetes. However, very little is known about how these regulatory programs are mis-regulated in diabetes. RNA-binding proteins (RBPs) are important regulators of posttranscriptional RNA networks, which are also dysregulated in diabetes. Human genetic studies provide new evidence that polymorphisms and mutations in RBPs are linked to diabetes. Therefore, we will discuss the emerging roles of RBPs in abnormal posttranscriptional gene expression in diabetes. Questions that will be addressed are: Which posttranscriptional mechanisms are disrupted in diabetes? Which RBPs are responsible for such changes under diabetic conditions? How are RBPs altered in diabetes? How does dysregulation of RBPs contribute to diabetes? Can we target RBPs using RNA-based methods to restore gene expression profiles in diabetic patients? Studying the evolving roles of RBPs in diabetes is critical not only for a comprehensive understanding of diabetes pathogenesis but also to design RNA-based therapeutic approaches for diabetic complications. WIREs RNA 2018, 9:e1459. doi: 10.1002/wrna.1459. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing Translation > Translation Regulation.

UR - http://www.scopus.com/inward/record.url?scp=85042146061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042146061&partnerID=8YFLogxK

U2 - 10.1002/wrna.1459

DO - 10.1002/wrna.1459

M3 - Review article

C2 - 29280295

AN - SCOPUS:85042146061

VL - 9

JO - Wiley interdisciplinary reviews. RNA

JF - Wiley interdisciplinary reviews. RNA

SN - 1757-7004

IS - 2

M1 - e1459

ER -